Profile: Inverness Medical Innovations Inc. provides women's health and other consumer & point-of-care health products. Our osteomark NTx delivers the measurement of cross-linked N-telopeptides of bone type I collagen (NTx). Our osteomark NTx assay is a competitive-inhibition enzyme linked immunosorbant assay that uses microwells in strips as the solid phase onto which NTx has been absorbed. Osteoporosis is the commonest disorder of bone metabolism, affecting 1 in 3 women over the age of 50 years and 1 in 8 men. The reagents used in our products are manufactured using monoclonal antibodies together with other chemical reagents. These active components are deposited onto special solid surfaces. The product performance is carefully steered to ensure exacting specifications are met.